Evidence map›Paper›PMID 41102965›Full record

ReviewCurrent drug discovery technologies2026

Unraveling Vitiligo: A Multifactorial, Autoimmune Disease - An Insight into its Pathophysiology and Power of Herbal Healing.

Nikita, Pravin Kumar, Mahendra Singh Ashawat, Vinay Pandit

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

NikitaDepartment of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P. 176031, India.ORCID 0009-0003-8830-1544
Pravin KumarDepartment of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P. 176031, India.ORCID 0000-0001-9853-4489
Mahendra Singh AshawatDepartment of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P. 176031, India.ORCID 0000-0001-7188-426X
Vinay PanditDepartment of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P. 176031, India.ORCID 0000-0002-0055-499X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitiligo, also known as leukoderma, is a chronic autoimmune skin disorder characterized by the progressive loss of melanocytes, leading to depigmented patches on the skin. While it is not life-threatening, the visible nature of the condition can significantly impact a patient's psychological and emotional well-being. This review aimed to provide a comprehensive overview of vitiligo, including its clinical presentation, pathogenesis, diagnostic methods, and current therapeutic options. Although various synthetic treatments are available, ranging from corticosteroids to phototherapy, their long-term effectiveness is often limited, and adverse effects are more common. As a result, there is a growing interest in natural and plant-based therapies that may offer safer and more sustainable alternatives. This review has highlighted the use of herbal bioactives and traditional medicines for vitiligo management, drawing upon the data sourced from PubMed, Google Scholar, Springer, and ClinicalTrials.gov databases. Key search terms for this review included vitiligo, herbal therapies, traditional medicine, animal models, Shwitra, and Baras. The review has also explored findings from animal models and clinical trials, contributing to our understanding of disease mechanisms and therapeutic efficacy. By integrating traditional knowledge with modern research, there is emerging potential for plant-derived compounds to serve as complementary or alternative options in vitiligo treatment. In conclusion, advancing our understanding of vitiligo's underlying mechanisms and embracing safer, evidence-based herbal therapies may pave the way toward more effective and holistic patient care.

Indexed as

Autoimmune DiseasesPhytotherapyVitiligoAnimalsHumansBakuchileukodermamelanogenesistraditional medicine systemtyrosinaseVitiligo

Identifiers

PMID41102965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.